{"entity":{"type":"insider","cik":"0001354034","url":"/insider/0001354034","json_url":"/insider/0001354034.json","name":"Samuels Camille D","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":19,"n_filings":13,"first":"2006-05-15","last":"2015-09-02","span_basis":"filed_date"},"name_variants":[{"name":"Samuels Camille D","source":"filing","n_filings":13,"first_seen":"2006-05-15","last_seen":"2015-09-02"}],"transactions":[{"id":8715169,"accession":"0001179110-15-012908","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-15-012908","line_url":"/filing/0001179110-15-012908#line-1","is_derivative":false,"issuer_cik":"0001354034","issuer_name":"KYTHERA BIOPHARMACEUTICALS INC","issuer_ticker":"KYTH","issuer_name_source":null,"issuer_url":"/issuer/0001354034","owner_cik":"0001354034","owner_name":"Samuels Camille D","owner_display_name":"Samuels Camille D","owner_url":"/insider/0001354034","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":250.0,"shares_display":"250","price_per_share":74.718,"price_display":"74.72","price_state":"stated","total_value":18679.5,"total_display":"18,679.50","total_whole":"18,680","shares_owned_after":13685.0,"shares_owned_after_display":"13,685","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-01","filed_date":"2015-09-02","scope":"insider"},{"id":8715067,"accession":"0001179110-15-011669","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-15-011669","line_url":"/filing/0001179110-15-011669#line-1","is_derivative":false,"issuer_cik":"0001354034","issuer_name":"KYTHERA BIOPHARMACEUTICALS INC","issuer_ticker":"KYTH","issuer_name_source":null,"issuer_url":"/issuer/0001354034","owner_cik":"0001354034","owner_name":"Samuels Camille D","owner_display_name":"Samuels Camille D","owner_url":"/insider/0001354034","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":250.0,"shares_display":"250","price_per_share":74.514,"price_display":"74.51","price_state":"stated","total_value":18628.5,"total_display":"18,628.50","total_whole":"18,629","shares_owned_after":13935.0,"shares_owned_after_display":"13,935","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-03","filed_date":"2015-08-04","scope":"insider"},{"id":8823187,"accession":"0001179110-15-010835","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-15-010835","line_url":"/filing/0001179110-15-010835#line-1","is_derivative":false,"issuer_cik":"0001354034","issuer_name":"KYTHERA BIOPHARMACEUTICALS INC","issuer_ticker":"KYTH","issuer_name_source":null,"issuer_url":"/issuer/0001354034","owner_cik":"0001354034","owner_name":"Samuels Camille D","owner_display_name":"Samuels Camille D","owner_url":"/insider/0001354034","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":250.0,"shares_display":"250","price_per_share":75.18,"price_display":"75.18","price_state":"stated","total_value":18795.0,"total_display":"18,795.00","total_whole":"18,795","shares_owned_after":14185.0,"shares_owned_after_display":"14,185","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-01","filed_date":"2015-07-02","scope":"insider"},{"id":8895777,"accession":"0001179110-15-008860","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-15-008860","line_url":"/filing/0001179110-15-008860#line-1","is_derivative":false,"issuer_cik":"0001354034","issuer_name":"KYTHERA BIOPHARMACEUTICALS INC","issuer_ticker":"KYTH","issuer_name_source":null,"issuer_url":"/issuer/0001354034","owner_cik":"0001354034","owner_name":"Samuels Camille D","owner_display_name":"Samuels Camille D","owner_url":"/insider/0001354034","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":250.0,"shares_display":"250","price_per_share":49.97,"price_display":"49.97","price_state":"stated","total_value":12492.5,"total_display":"12,492.50","total_whole":"12,493","shares_owned_after":14435.0,"shares_owned_after_display":"14,435","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-01","filed_date":"2015-06-02","scope":"insider"},{"id":8684662,"accession":"0001179110-15-006970","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-15-006970","line_url":"/filing/0001179110-15-006970","is_derivative":false,"issuer_cik":"0001354034","issuer_name":"KYTHERA BIOPHARMACEUTICALS INC","issuer_ticker":"KYTH","issuer_name_source":null,"issuer_url":"/issuer/0001354034","owner_cik":"0001354034","owner_name":"Samuels Camille D","owner_display_name":"Samuels Camille D","owner_url":"/insider/0001354034","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":250.0,"shares_display":"250","price_per_share":44.7156,"price_display":"44.72","price_state":"stated","total_value":11178.9,"total_display":"11,178.90","total_whole":"11,179","shares_owned_after":14685.0,"shares_owned_after_display":"14,685","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-01","filed_date":"2015-05-04","scope":"insider","n_lines":2},{"id":8207653,"accession":"0001179110-15-005897","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-15-005897","line_url":"/filing/0001179110-15-005897","is_derivative":false,"issuer_cik":"0001354034","issuer_name":"KYTHERA BIOPHARMACEUTICALS INC","issuer_ticker":"KYTH","issuer_name_source":null,"issuer_url":"/issuer/0001354034","owner_cik":"0001354034","owner_name":"Samuels Camille D","owner_display_name":"Samuels Camille D","owner_url":"/insider/0001354034","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":250.0,"shares_display":"250","price_per_share":48.93,"price_display":"48.93","price_state":"stated","total_value":12232.5,"total_display":"12,232.50","total_whole":"12,233","shares_owned_after":15035.0,"shares_owned_after_display":"15,035","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-01","filed_date":"2015-04-02","scope":"insider","n_lines":2},{"id":8714723,"accession":"0001179110-15-003871","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-15-003871","line_url":"/filing/0001179110-15-003871","is_derivative":false,"issuer_cik":"0001354034","issuer_name":"KYTHERA BIOPHARMACEUTICALS INC","issuer_ticker":"KYTH","issuer_name_source":null,"issuer_url":"/issuer/0001354034","owner_cik":"0001354034","owner_name":"Samuels Camille D","owner_display_name":"Samuels Camille D","owner_url":"/insider/0001354034","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":250.0,"shares_display":"250","price_per_share":40.506,"price_display":"40.51","price_state":"stated","total_value":10126.5,"total_display":"10,126.50","total_whole":"10,127","shares_owned_after":15285.0,"shares_owned_after_display":"15,285","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-02","filed_date":"2015-03-03","scope":"insider","n_lines":2},{"id":8609588,"accession":"0001179110-15-001556","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-15-001556","line_url":"/filing/0001179110-15-001556#line-1","is_derivative":false,"issuer_cik":"0001354034","issuer_name":"KYTHERA BIOPHARMACEUTICALS INC","issuer_ticker":"KYTH","issuer_name_source":null,"issuer_url":"/issuer/0001354034","owner_cik":"0001354034","owner_name":"Samuels Camille D","owner_display_name":"Samuels Camille D","owner_url":"/insider/0001354034","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":250.0,"shares_display":"250","price_per_share":37.312,"price_display":"37.31","price_state":"stated","total_value":9328.0,"total_display":"9,328.00","total_whole":"9,328","shares_owned_after":15435.0,"shares_owned_after_display":"15,435","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-02","filed_date":"2015-02-03","scope":"insider"},{"id":8151658,"accession":"0001179110-15-001100","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-15-001100","line_url":"/filing/0001179110-15-001100","is_derivative":false,"issuer_cik":"0001354034","issuer_name":"KYTHERA BIOPHARMACEUTICALS INC","issuer_ticker":"KYTH","issuer_name_source":null,"issuer_url":"/issuer/0001354034","owner_cik":"0001354034","owner_name":"Samuels Camille D","owner_display_name":"Samuels Camille D","owner_url":"/insider/0001354034","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":250.0,"shares_display":"250","price_per_share":36.7,"price_display":"36.70","price_state":"stated","total_value":9175.0,"total_display":"9,175.00","total_whole":"9,175","shares_owned_after":15685.0,"shares_owned_after_display":"15,685","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-16","filed_date":"2015-01-21","scope":"insider","n_lines":2},{"id":5674874,"accession":"0001209191-09-045187","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-045187","line_url":"/filing/0001209191-09-045187#line-1","is_derivative":false,"issuer_cik":"0001181338","issuer_name":"HELICOS BIOSCIENCES CORP","issuer_ticker":"HLCS","issuer_name_source":null,"issuer_url":"/issuer/0001181338","owner_cik":null,"owner_name":"JAFFE ROSS A MD; Warden Charles M; LINK WILLIAM J PHD; Samuels Camille D; Bolzon Bradley J PhD; ROBERTSON REBECCA B; Versant Venture Capital II, LP","owner_display_name":"JAFFE ROSS A MD","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":242931.0,"shares_display":"242,931","price_per_share":2.5728,"price_display":"2.57","price_state":"stated","total_value":625012.8768,"total_display":"625,012.88","total_whole":"625,013","shares_owned_after":10709818.0,"shares_owned_after_display":"10,709,818","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-09-18","filed_date":"2009-09-21","scope":"insider"},{"id":3618520,"accession":"0001209191-08-067548","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-08-067548","line_url":"/filing/0001209191-08-067548#line-3","is_derivative":false,"issuer_cik":"0001181338","issuer_name":"HELICOS BIOSCIENCES CORP","issuer_ticker":"HLCS","issuer_name_source":null,"issuer_url":"/issuer/0001181338","owner_cik":null,"owner_name":"ROBERTSON REBECCA B; Versant Venture Capital II, LP; LINK WILLIAM J PHD; Samuels Camille D; JAFFE ROSS A MD; Warden Charles M; Bolzon Bradley J PhD","owner_display_name":"ROBERTSON REBECCA B","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8386581.0,"shares_display":"8,386,581","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":10466887.0,"shares_owned_after_display":"10,466,887","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-12-23","filed_date":"2008-12-29","scope":"insider"},{"id":3618519,"accession":"0001209191-08-067548","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-08-067548","line_url":"/filing/0001209191-08-067548#line-2","is_derivative":false,"issuer_cik":"0001181338","issuer_name":"HELICOS BIOSCIENCES CORP","issuer_ticker":"HLCS","issuer_name_source":null,"issuer_url":"/issuer/0001181338","owner_cik":null,"owner_name":"ROBERTSON REBECCA B; Versant Venture Capital II, LP; LINK WILLIAM J PHD; Samuels Camille D; JAFFE ROSS A MD; Warden Charles M; Bolzon Bradley J PhD","owner_display_name":"ROBERTSON REBECCA B","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":159154.0,"shares_display":"159,154","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":196522.0,"shares_owned_after_display":"196,522","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-12-23","filed_date":"2008-12-29","scope":"insider"},{"id":3618518,"accession":"0001209191-08-067548","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-08-067548","line_url":"/filing/0001209191-08-067548#line-1","is_derivative":false,"issuer_cik":"0001181338","issuer_name":"HELICOS BIOSCIENCES CORP","issuer_ticker":"HLCS","issuer_name_source":null,"issuer_url":"/issuer/0001181338","owner_cik":null,"owner_name":"ROBERTSON REBECCA B; Versant Venture Capital II, LP; LINK WILLIAM J PHD; Samuels Camille D; JAFFE ROSS A MD; Warden Charles M; Bolzon Bradley J PhD","owner_display_name":"ROBERTSON REBECCA B","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":74955.0,"shares_display":"74,955","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":92533.0,"shares_owned_after_display":"92,533","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-12-23","filed_date":"2008-12-29","scope":"insider"},{"id":8507761,"accession":"0001209191-07-034581","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-07-034581","line_url":"/filing/0001209191-07-034581#line-4","is_derivative":false,"issuer_cik":"0001181338","issuer_name":"HELICOS BIOSCIENCES CORP","issuer_ticker":"HLCS","issuer_name_source":null,"issuer_url":"/issuer/0001181338","owner_cik":null,"owner_name":"Samuels Camille D; Warden Charles M; JAFFE ROSS A MD; Versant Ventures II LLC; LINK WILLIAM J PHD; Bolzon Bradley J PhD; ROBERTSON REBECCA B; Versant Side Fund II, LP; Versant Venture Capital II, LP; Versant Affiliates Fund II-A, LP","owner_display_name":"Samuels Camille D","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":111111.0,"shares_display":"111,111","price_per_share":9.0,"price_display":"9.00","price_state":"stated","total_value":999999.0,"total_display":"999,999.00","total_whole":"999,999","shares_owned_after":111111.0,"shares_owned_after_display":"111,111","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-05-30","filed_date":"2007-06-01","scope":"insider"},{"id":3772930,"accession":"0001181431-06-030242","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001181431-06-030242","line_url":"/filing/0001181431-06-030242#line-6","is_derivative":false,"issuer_cik":"0001178711","issuer_name":"NOVACEA INC","issuer_ticker":"NOVC","issuer_name_source":null,"issuer_url":"/issuer/0001178711","owner_cik":null,"owner_name":"Versant Venture Capital II, LP; Versant Affiliates Fund II-A, LP; LUBASH BARBARA N; MILDER DONALD B; ATWOOD BRIAN G; COLELLA SAMUEL D; Samuels Camille D; Versant Side Fund II, LP; Versant Ventures II LLC; JAFFE ROSS A MD","owner_display_name":"Versant Venture Capital II, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock, par value $0.001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":230769.0,"shares_display":"230,769","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":2044744.0,"shares_owned_after_display":"2,044,744","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-05-15","filed_date":"2006-05-15","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":13,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":13,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":13},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001436304","name":"KYTHERA BIOPHARMACEUTICALS INC","url":"/issuer/0001436304","role":"Director","n_filings":9,"first_seen":"2015-01-21","last_seen":"2015-09-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001274563","name":"HELICOS BIOSCIENCES CORP","url":"/issuer/0001274563","role":"Ten percent owner","n_filings":3,"first_seen":"2007-06-01","last_seen":"2009-09-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001178711","name":"NOVACEA INC","url":"/issuer/0001178711","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2006-05-15","last_seen":"2006-05-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001354034","retrieved_at":"2026-08-25T20:31:50+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}